Lateral pelvic lymph node dissection or chemoradiotherapy: Which is the procedure of choice to reduce local recurrence rate in lower rectal cancer?

Annals of Surgery

Volumn 248, Issue 2, 2008, Pages 342-343

  Watanabe, Toshiaki ^a   Matsuda, Keiji ^a   Nozawa, Keijiro ^a   Kobunai, Takashi ^a  

^a TEIKYO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT CHEMOTHERAPY; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; DISEASE FREE SURVIVAL; LETTER; LYMPH NODE DISSECTION; OVERALL SURVIVAL; PELVIS LYMPH NODE; POSTOPERATIVE CARE; PRIORITY JOURNAL; RECTUM CANCER; TUMOR LOCALIZATION; ADJUVANT THERAPY; COMPARATIVE STUDY; FEMALE; HUMAN; LYMPH NODE; LYMPHADENECTOMY; MALE; METHODOLOGY; MORTALITY; MULTIMODALITY CANCER THERAPY; NOTE; PATHOLOGY; PELVIS; PROGNOSIS; RECTUM TUMOR; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SURVIVAL; TREATMENT OUTCOME; TUMOR RECURRENCE;

CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; MALE; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PELVIS; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RECTAL NEOPLASMS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 49849095283     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e3181820d0d     Document Type: Letter

References (7)

1. Kim JC, Takahashi K, Yu CS, et al. Comparative outcome between chemoradio- therapy and lateral pelvic lymph node dissection following total mesorectal excision in rectal cancer. Ann Surg. 2007;246:754-762.
2. Watanabe T, Tsurita G, Muto T, et al. Extended lymphadenectomy and preoperative radiotherapy for lower rectal cancers. Surgery. 2002; 132:27-33.
3. Mori T, Takahashi K, Yasuno M. Radical resection with autonomic nerve preservation and lymph node dissection techniques in lower rectal cancer surgery and its results: the impact of lateral lymph node dissection. Langenbecks Arch Surg. 1998;383:409-415.
4. Sakamoto J, Hamada C, Yoshida S, et al. An individual patient data meta-analysis of adju-vant therapy with uracil-tegafur (UFT) in patients with curatively resected rectal cancer. Br J Cancer. 2007;96:1170-1177.
5. Akasu T, Moriya Y, Ohashi Y, et al. National Surgical Adjuvant Study of Colorectal Cancer. Adjuvant chemotherapy with uracil-tegafur for pathological stage III rectal cancer after meso- rectal excision with selective lateral pelvic lymphadenectomy: a multicenter randomized controlled trial. Jpn J Clin Oncol. 2006;36: 237-244.
6. Japanese Classification of Colorectal Carcinoma. Japanese Society for Cancer of the Colon and Rectum. First English Edition. Tokyo: Kanehara & Co., LTD; 1997.
7. Peeters KC, Marijnen CA, Nagtegaal ID, et al. Dutch Colorectal Cancer Group. The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg. 2007;246:693-701.